[00:00:04] Doug McIntyre: Lee.
Altria (MO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
[00:00:04] Doug McIntyre: Lee, I wanna tell you what I think investors need to take into account now.
Altria's strong Q2 earnings, robust cash flows, and low P/E support my bullish outlook, despite ongoing cigarette declines and regulatory risks. Growth drivers include expanding oral tobacco market share, potential NJOY relaunch, and upcoming On! PLUS launch pending FDA approval. Balance sheet strength, deleveraging progress, and a likely dividend increase add to Altria's investment appeal and upside potential.
MO's on! sales jump in the second quarter, but MST declines and pouch share losses raise questions about sustaining growth.
Stocks with high yields are not supposed to participate in market rallies. Their role is to provide stability and a safe dividend.
Great things require time and patience; so does wealth building. Compound interest, the "eighth wonder of the world", can quietly do the work for you. We discuss our time-tested dividend growth picks with yields of up to 7%.
Altria Group, Inc.'s ( MO ) push into smoke-free products gained further traction in the second quarter of 2025, led by its oral nicotine pouch brand, on!. Shipments of on!
Altria (MO) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Altria beat Q2'25 earnings and revenue estimates and grew its core operating segment profits by more than 4% Y/Y. The alternative products segment is seeing expanding market growth while the traditional tobacco segment remained highly profitable. The tobacco firm narrowed its full-year EPS guidance and maintains high excess dividend coverage, supporting a robust 7% dividend yield for investors.
Altria offers a strong, sustainable 6.5% dividend yield, supported by robust earnings and disciplined capital allocation. Growth in alternative tobacco, especially oral and e-Vapor products, offsets declines in traditional smokeables and secures long-term business viability. Despite industry headwinds, Altria delivers 8.3% YoY EPS growth and raises guidance, trading at an attractive 11.5x P/E ratio.
Altria Group Inc. is the notorious tobacco giant formerly known as Philip Morris.